Elamin H Elbasha
Overview
Explore the profile of Elamin H Elbasha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
950
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lang J, Kura K, Garba S, Elbasha E, Chen Y
Vaccine
. 2024 Feb;
42(8):1918-1927.
PMID: 38368224
Background: A recent study comparing results of multiple cost-effectiveness analyses (CEAs) in a hypothetical population found that monoclonal antibody (mAb) immunoprophylaxis for respiratory syncytial virus (RSV) in infants averted fewer...
2.
3.
Elbasha E
Pharmacoeconomics
. 2022 Feb;
40(5):497-507.
PMID: 35137340
Accounting for risk attitudes in medical decision making under uncertainty has attracted little research. A recent proposal recommended using the results of a cost-effectiveness analysis to construct a cost-effectiveness risk-aversion...
4.
Elbasha E, Gumel A
J Math Biol
. 2021 Dec;
83(6-7):73.
PMID: 34878609
It has been suggested, without rigorous mathematical analysis, that the classical vaccine-induced herd immunity threshold (HIT) assuming a homogeneous population can be substantially higher than the minimum HIT obtained when...
5.
Elbasha E, Choi Y, Daniels V, Goveia M
Vaccine
. 2021 Sep;
39(42):6315-6321.
PMID: 34538694
Background: Despite routine vaccination of children against hepatitis A (HepA), a large segment of the United States population remains unvaccinated, imposing a risk of hepatitis A virus (HAV) to adolescents...
6.
Malik T, Mohammed-Awel J, Gumel A, Elbasha E
J Biol Dyn
. 2021 Feb;
15(sup1):S214-S247.
PMID: 33594952
Although pneumococcal vaccines are quite effective in reducing disease burden, factors such as imperfect vaccine efficacy and serotype replacement present an important challenge against realizing direct and herd protection benefits...
7.
Gumel A, Iboi E, Ngonghala C, Elbasha E
Infect Dis Model
. 2021 Jan;
6:148-168.
PMID: 33474518
The novel coronavirus (COVID-19) pandemic that emerged from Wuhan city in December 2019 overwhelmed health systems and paralyzed economies around the world. It became the most important public health challenge...
8.
Cody P, Tobe K, Abe M, Elbasha E
BMC Infect Dis
. 2021 Jan;
21(1):11.
PMID: 33407188
Background: Combined with cancer screening programs, vaccination against human papillomavirus (HPV) can significantly reduce the high health and economic burden of HPV-related disease in Japan. The objective of this study...
9.
Hayajneh W, Daniels V, James C, Kanibir M, Pilsbury M, Marks M, et al.
BMC Infect Dis
. 2019 Oct;
19(1):904.
PMID: 31660877
Following publication of the original article, the authors noted the following.
10.
Jahn B, Kurzthaler C, Chhatwal J, Elbasha E, Conrads-Frank A, Rochau U, et al.
Med Decis Making
. 2019 Jun;
39(5):509-522.
PMID: 31253053
. In state-transition models (STMs), decision problems are conceptualized using health states and transitions among those health states after predefined time cycles. The naive, commonly applied method (C) for cycle...